Abstract
The highest incidence of cancer in American men, next to cancers of the skin and lung, is prostate cancer. Present estimates indicate that about one out of 11 American men will develop prostate cancer. In 1990 there were an estimated 106,000 new cases annually in the United States, and nearly one-third (30,000) of these patients died of the disease. In Japan, the age adjusted prostate cancer mortality rate is significantly lower (2 per 100,000) than in the U.S. (14 per 100,000). However, the incidence of occult or latent prostatic cancer is similar in both countries. In the following pages, data from both countries are reported which offer potential insight into the etiology and progression of prostate cancer in American and Japanese patients.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Waterhouse J., Muir C.S., Correa P. and Powell J. (eds.), Cancer incidence in five continents, Vol. 3, Lyon, France, IARC (1976).
American Cancer Society, Cancer Facts and Figures, 1990.
Carter H.B. and Coffey D.S., The Prostate: An increasing medical problem. The Prostate 16:39–48, (1990).
Dohm G., Das Prostatakarzinom und die Bedeutung seiner Früherkennung. Med. Unserer Zeit 5:134 (1978).
Akazaki K. and Stemmermann G.N., Comparative study of latent carcinoma of the prostate among Japanese in Japan and Hawaii. J.N.C.I. 50:1137–1144, (1973).
Yatani R., Itsuo K., Sugimura Y., Takanari H., Shiraishi T., Nakano H., Sakakura T., Shimazaki J., Hayashi T. and Stemmermann G.N., Histopathological comparison of prostatic carcinoma between Japanese in Japan and Japanese-Americans in Hawaii, in: “Prostate Cancer: The Second Tokyo Symposium”, pp 128–130, Karr J.P. and Yamanaka H., eds., Elsevier, New York, (1989).
Yatani R., Chigusa I., Akazaki K., Stemmermann G.N., Welsh R.A. and Correa P., Geographic pathology of latent prostatic carcinoma, Int. J. Cancer 29:611–616 (1982).
Guileyardo J.M., Johnson W.D., Welsh R.A., Akazaki K. and Correa P., Prevalence of latent prostate carcinoma in two U.S. populations. J.N.C.I., 65:311–316, (1980).
Ross R.K., Paganini-Hill A. and Henderson B.E., The etiology of prostate cancer: what does the epidemiology suggest? The Prostate 4:333–344 (1983).
Waterhouse J., Muir C., Shanmugaratnam K. and Power J. (eds.), Cancer incidence in five countries, Vol IV, IARC Scientific Publications No. 42, Lyon, France: International Agency for Research on Cancer (1982).
Horm J.W., Asire A.J., Young J.L. and Pollack E.S., Cancer incidence and mortality in the United States: 1973-81, NIH Publication No. 85-1837, National Cancer Institute (1984).
Hutchinson G.B., Incidence and etiology of prostate cancer, Urology 17:4–10 (1981).
Marshall E., Experts clash over science data, Science 250:900–902 (1990).
U.S. Department of Health and Human Services: Cancer Statistics Review 1973-1986, National Cancer Institute Surveillance Program (1989).
Shida K., Introduction to the clinical and research programs of the Japan National Prostatic Cancer Project Team, The Prostate (Supplement 1):5–8 (1981).
Aoki K., Sasaki R. and Mizuno S., Changes in mortality of all forms of malignant neoplasms among Japanese for the last decades, Gann. Monograph on Cancer Research 33:33–43 (1987).
Segi M., Kurihara M. and Matsuyama T., Cancer mortality for selected sites in 24 countries, No. 5 (1964–1965), p 120, Department of Public Health, Tokuku University School of Medicine, Sendai, Japan (1969).
Haenszel W. and Kurihara M., Studies of Japanese migrants, I. Mortality from cancer and other diseases among Japanese in the United States, Natl. Cancer Inst. 40:43–68 (1968).
Mettlin C., Natarajan N. and Murphy G., Recent patterns of care of prostate cancer patients in the United States: results from the surveys of the American College of Surgeons Commission on Cancer, Int. Advances in Surg. Oncol. 5:277–321 (1982).
Sondik E., Incidence, survival and mortality trends in prostate cancer., in: “A Multidisciplinary Analysis of Controversies in the Management of Prostate (Coffey D.S., Resnick M.I., Door A.F. and Karr J.P. eds.), Plenum Press, New York, pp 9–16 (1988).
Byar D.P., VACURG studies on prostate cancer and its treatment, in: “Urologic Pathology: The Prostate” (Tannenbaum M., ed.) pp 241–267, Lea and Febiger, Philadelphia, PA (1977).
Berge T. and Lundberg S., Cancer in Malmö 1958–1969; an autopsy study, Acta Pathologica et Microbiological Scandinavica Section A, Supplement No. 260. (1977).
Weiss L. and Gilbert H.A. (eds.), Bone Metastasis, pp 54–55, G.K. Hall Medical Publishers, Boston, MA (1981).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Karr, J.P. (1992). Prostate Cancer in the United States and Japan. In: Karr, J.P., Yamanaka, H. (eds) Prostate Cancer and Bone Metastasis. Advances in Experimental Medicine and Biology, vol 324. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3398-6_3
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3398-6_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6501-3
Online ISBN: 978-1-4615-3398-6
eBook Packages: Springer Book Archive